CIK 0000946644 · Non-accelerated filer<br>Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 520845822
- Phone
- 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- Open-market buys, last 90 days
- $44,466
- in 11 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$44,466. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-04 | STRAYER DAVID R Chief Science/Medical Officer | Option exercise | +50,000 | 50,000 | ||
| 2019-03-04 | STRAYER DAVID R Chief Science/Medical Officer | Option exercise · Subr Rights(to buy) | +10 | $1,000.00 | $10K | 0 |
| 2019-02-28 | APPELROUTH STEWART Director | Option exercise | +40 | 40 | ||
| 2019-02-28 | APPELROUTH STEWART Director | Option exercise | +200,000 | 200,000 | ||
| 2019-02-28 | APPELROUTH STEWART Director | Option exercise · Subr Rights(to buy) | +40 | $1,000.00 | $40K | 0 |
| 2019-02-28 | SPRINGATE WAYNE S Sr. VP of Operations | Option exercise | +10 | 10 | ||
| 2019-02-28 | SPRINGATE WAYNE S Sr. VP of Operations | Option exercise | +50,000 | 50,000 | ||
| 2019-02-28 | SPRINGATE WAYNE S Sr. VP of Operations | Option exercise · Subr Rights(to buy) | +10 | $1,000.00 | $10K | 0 |
| 2019-02-27 | RODINO III PETER W. Dir Govt Relations/Sectry | Option exercise | +18 | 18 | ||
| 2019-02-27 | RODINO III PETER W. Dir Govt Relations/Sectry | Option exercise | +90,000 | 90,000 | ||
| 2019-02-27 | RODINO III PETER W. Dir Govt Relations/Sectry | Option exercise · Subr Rights(to buy) | +18 | $1,000.00 | $18K | 0 |
| 2019-02-27 | PASCALE ADAM CFO | Option exercise | +10 | 10 | ||
| 2019-02-27 | PASCALE ADAM CFO | Option exercise | +50,000 | 50,000 | ||
| 2019-02-27 | PASCALE ADAM CFO | Option exercise · Subr Rights(to buy) | +10 | $1,000.00 | $10K | 0 |
| 2019-02-27 | EQUELS THOMAS K. Exec. Vice Chairman/CEO/Pres. | Option exercise | +65 | 65 | ||
| 2019-02-27 | EQUELS THOMAS K. Exec. Vice Chairman/CEO/Pres. | Option exercise | +325,000 | 325,000 | ||
| 2019-02-27 | EQUELS THOMAS K. Exec. Vice Chairman/CEO/Pres. | Option exercise · Subr Rights(to buy) | +65 | $1,000.00 | $65K | 0 |
| 2019-01-28 | APPELROUTH STEWART Director | Grant or award · Options to buy Common Stock | +207,343 | 207,343 | ||
| 2019-01-28 | APPELROUTH STEWART Director | Grant or award · Options to buy Common Stock | +50,000 | 50,000 | ||
| 2019-01-28 | MITCHELL WILLIAM M Director | Grant or award · Options to buy Common Stock | +207,343 | 207,343 |
Page 12 of 14 · 264 trades